CA Patent

CA2992211C — Prodrugs of fumarates and their use in treating various diseases

Assigned to Alkermes Pharma Ireland Ltd · Expires 2021-09-21 · 5y expired

What this patent protects

The present invention relates to various derivatives of monomethyl fumarate which offer improved properties. The invention provides compounds of formula (I), and pharmaceutical compositions thereof, which are suitable for long-term administration.

USPTO Abstract

The present invention relates to various derivatives of monomethyl fumarate which offer improved properties. The invention provides compounds of formula (I), and pharmaceutical compositions thereof, which are suitable for long-term administration.

Drugs covered by this patent

Patent Metadata

Patent number
CA2992211C
Jurisdiction
CA
Classification
Expires
2021-09-21
Drug substance claim
No
Drug product claim
No
Assignee
Alkermes Pharma Ireland Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.